Skip to main content

Chromium (Cr³⁺)

Cr³⁺

Overview

Chromium is an essential trace mineral present in small amounts in many whole foods. Nutritionally relevant forms are typically trivalent chromium (Cr³⁺), which has been studied for roles in insulin signalling and glucose metabolism. Within the BRAIN Framework, chromium is interpreted as a supportive micronutrient in BRS6 — Metabolic & Neuroendocrine Stress, particularly around insulin sensitivity and glucose disposal rather than as a standalone treatment. Food sources include broccoli, whole grains, nuts, brewer's yeast, and animal tissues, though content varies with soil and processing.

Dietary absorption and meal context

  • Form note: Dietary and supplemental chromium is discussed primarily as Cr³⁺; hexavalent chromium (Cr⁶⁺) is a toxic industrial exposure form, not a nutritional target.
  • Food-first pattern: Whole grains, legumes, nuts, broccoli, and minimally processed animal foods contribute dietary chromium within mixed meals.
  • Interpretation: Effects on glycaemic control are dose- and context-dependent; pharmacological doses reported in reviews exceed typical dietary intake and should not be extrapolated to routine food amounts.

Recipes

no recipes found (no foods contain this substance)

Foods

no foods found

Biological Mechanisms and Implications

Biological TargetTherapeutic AreasMechanism of Action
BRS1 - Neurotransmitter RegulationInsulin shifts plasma amino acid balance and can influence tyrosine availability for catecholamine synthesis; adequate glucose–insulin handling supported by micronutrient context including chromium may indirectly support dopaminergic signalling environments
BRS6 - Metabolic & Neuroendocrine StressTrivalent chromium (Cr³⁺) may support insulin responsiveness and post-prandial glucose disposal as part of broader dietary micronutrient context; pharmacological doses have been studied for glycaemic and insulin-sensitivity effects, though food-first intake remains the primary framework lever

References

  • Micronutrients including magnesium and chromium may contribute supportive signalling conditions for insulin responsiveness and glucose metabolism within dietary patterns, interpreted as supportive rather than deterministic BRS6-FM1-PM3 context
  • Evidence reviews note that pharmacological doses of chromium, among other micronutrients, have been studied for glycaemic control and insulin-sensitivity effects at multiples of the RDA Kennedy 2016
  • Preserving food matrix and glycaemic stability supports brain insulin sensitivity and dopamine–insulin coupling relevant to motivation and impulse regulation Gruber et al. 2023
  • Chronic low-grade inflammation and impaired insulin sensitivity can compromise dopamine signalling and cognitive resilience Mohammad and Thiemermann 2021